By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – AB Sciex today announced a collaboration with researchers at the University of Melbourne to develop standardized testing methodologies for the study of biopharmaceutical metabolism.

The project will be based on an approach developed by scientists at the university on the AB Sciex QTrap 5500 system to evaluate how protein-based drugs break down in vivo, something that drug discovery researchers currently cannot do.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."